Testing Ipatasertib as Potentially Targeted Treatment in Cancers With AKT Genetic Changes (MATCH - Subprotocol Z1K)
Clinical trial NCT06400251 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06400251
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-08
- Primary completion
- 2023-06-27
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.